{"slideshow_credits": null, "snippet": "A psychiatrist says regulators allow some deviations between brand name and generic medications.", "abstract": null, "section_name": "Opinion", "print_page": "18", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2013/10/12/opinion/prescribing-generic-drugs.html", "lead_paragraph": "A psychiatrist says regulators allow some deviations between brand name and generic medications.", "headline": {"main": "Prescribing Generic Drugs", "print_headline": "Prescribing Generic Drugs", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "5258a22b38f0d81989741d44", "word_count": "193", "multimedia": [], "pub_date": "2013-10-12T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Drescher, Jack", "name": "persons", "is_major": "N", "rank": "4"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}